Back to search
Pediatric Growth Hormone Deficiency (PGHD)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pediatric Growth Hormone Deficiency (PGHD) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pediatric Growth Hormone Deficiency (PGHD) trials you may qualify forThis study comprises two phases: Phase Ib and Phase II. Phase Ib is a multicenter, randomized, open-label, active-controlled, single-dose, dose-escalation to as…
This is a two-part clinical study for children with growth hormone deficiency. In the first part, participants will be randomly assigned to receive different do…
The purpose of this study is to investigate whether PEG-rhGH with new preparation is bioequivalent to PEG-rhGH with present preparation.
The purpose of this study is to compare the pharmacokinetics of the two different PEG-rhGH preparations.
The purpose of this study is to compare the pharmacokinetics of the two different PEG-rhGH preparations after a single administration.
The purpose of this study is to compare the pharmacokinetics of the two different PEG-rhGH preparations after a single administration.
The purpose of this study is to investigate whether PEG-rhGH with new preparation is bioequivalent to PEG-rhGH with present preparation.
The purpose of this study is to investigate whether PEG-rhGH with new preparation is bioequivalent to PEG-rhGH with present preparation.
The goals of this single site trial are to study the pharmacokinetics (PK) and pharmacodynamics of LUM-201 and effects of LUM-201 administration on growth hormo…
This is a Phase 1b/2a study of VRS-317 (long-acting growth hormone) in pediatric patients with growth hormone deficiency. During Phase 1b, pediatric patients ea…
Protocol 13VR3 is is a multi-center, open-label study assessing long-term somavaratan administration. Patients will be monitored for safety throughout their pa…